Literature DB >> 18787061

Canalicular Mrp2 localization is reversibly regulated by the intracellular redox status.

Shuichi Sekine1, Kousei Ito, Toshiharu Horie.   

Abstract

Oxidative stress is known to be a common feature of cholestatic syndrome. We have described the internalization of multidrug resistance-associated protein 2 (Mrp2), a biliary transporter involved in bile salt-independent bile flow, under acute oxidative stress, and a series of signaling pathways finally leading to the activation of novel protein kinase C were involved in this mechanism; however, it has been unclear whether the internalized Mrp2 localization was relocalized to the canalicular membrane when the intracellular redox status was recovered from oxidative stress. In this study, we demonstrated that decreased canalicular expression of Mrp2 induced by tertiary-butyl hydroperoxide (t-BHP) was recovered to the canalicular membrane by the replenishment of GSH by GSH-ethyl ester, a cell-permeable form of GSH. Moreover, pretreatment of isolated rat hepatocytes with colchicine and PKA inhibitor did not affect the t-BHP-induced Mrp2 internalization process but did prevent the Mrp2 recycling process induced by GSH replenishment. Moreover, intracellular cAMP concentration similarly changed with the change of intracellular GSH content. Taken together, our data clearly indicate that the redox-sensitive balance of PKA/PKC activation regulates the reversible Mrp2 localization in two different pathways, the microtubule-independent internalization pathway and -dependent recycling pathway of Mrp2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787061     DOI: 10.1152/ajpgi.90404.2008

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  8 in total

1.  Altered regulation of hepatic efflux transporters disrupts acetaminophen disposition in pediatric nonalcoholic steatohepatitis.

Authors:  Mark J Canet; Matthew D Merrell; Rhiannon N Hardwick; Amy M Bataille; Sarah N Campion; Daniel W Ferreira; Stavra A Xanthakos; Jose E Manautou; H Hesham A-Kader; Robert P Erickson; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2015-03-18       Impact factor: 3.922

2.  Nonalcoholic Steatohepatitis Modulates Membrane Protein Retrieval and Insertion Processes.

Authors:  A L Dzierlenga; J D Clarke; N J Cherrington
Journal:  Drug Metab Dispos       Date:  2016-09-07       Impact factor: 3.922

Review 3.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

4.  A Critical Evaluation of Liver Pathology in Humans with Danon Disease and Experimental Correlates in a Rat Model of LAMP-2 Deficiency.

Authors:  Lu Wang; Jingbo Wang; Weile Cai; Yongquan Shi; Xinmin Zhou; Guanya Guo; Changcun Guo; Xiaofeng Huang; Zheyi Han; Shuai Zhang; Shuoyi Ma; Xia Zhou; Daiming Fan; M Eric Gershwin; Ying Han
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

5.  Misregulation of membrane trafficking processes in human nonalcoholic steatohepatitis.

Authors:  Anika L Dzierlenga; Nathan J Cherrington
Journal:  J Biochem Mol Toxicol       Date:  2018-01-17       Impact factor: 3.642

6.  Effects of High-cholesterol Diet on Pravastatin Disposition in the Perfused Rat Liver.

Authors:  Atsushi Kawase; Ayumi Handa; Masahiro Iwaki
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

7.  Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease.

Authors:  Rhiannon N Hardwick; Craig D Fisher; Mark J Canet; George L Scheffer; Nathan J Cherrington
Journal:  Drug Metab Dispos       Date:  2011-08-30       Impact factor: 3.922

Review 8.  The molecular pathogenesis of cholestasis in sepsis.

Authors:  Harjit K Bhogal; Arun J Sanyal
Journal:  Front Biosci (Elite Ed)       Date:  2013-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.